Fall Line Capital
VC Fund
San Mateo, United States
Fall Line Capital is a VC fund in San Mateo focused on Biotechnology and Agriculture. Fall Line Capital primarily seeks investment in broadacre farmland and agricultural technologies. The firm engages in purchasing and actively managing farmland throughout the United States, and by investing in technology companies that are strategic to our landholdings. Fall Line Capital's primary goal is to realize untapped productivity infarmland.
- Total investments:
- 59
- Last investment:
- Lead investor:
- 25%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Fall Line Capital invests in
Stages Fall Line Capital invests in
Countries Fall Line Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $3M–$14M
- Series A
- $7.5M–$32M
- Series B
- $19M–$46M
Investment Focus
Industry
- Biotechnology 13 (22%)
- Agriculture 12 (20%)
- AgTech 10 (17%)
- Farming 8 (14%)
- Software 7 (12%)
Stage
- Series A 14 (24%)
- Seed 13 (22%)
- Series B 11 (19%)
- Series C 6 (10%)
- Series D 3 (5%)
Country
- United States 26 (44%)
- Israel 2 (3%)
- Canada 1 (2%)
- France 1 (2%)
- Argentina 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Libby Spalding
Vice President
|
Vice President | Total investments: 1 | Find email | |
Wade Condrey
Head of Southern Operations
|
Head of Southern Operations | Total investments: 0 | Find email | |
Yanniv Dorone
Senior Vice President
|
Senior Vice President | Total investments: 1 | Find email | |
Baptiste Tellier
Director
|
Director | Total investments: 3 | Find email | |
Clay Mitchell
Co-founder & Managing Director
|
Co-founder & Managing Director | Total investments: 8 | Find email | |
| See all 14 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ethernovia
|
Developing an Ethernet system sophisticated enough to process the bandwidth demands of the future requires expert integration at multiple levels. By unifying the vehicle network, the Ethernovia system has the power to dramatically alter how cars are designed and built. | $90M / Series B / Jan 20, 2026 | |
Ukko
|
Ukko is a biotech firm focused on creating safe immunotherapies for quickly addressing allergies and other immune-related disorders. The company utilizes a unique technology platform that combines computational protein design with mRNA/LNP delivery to alter allergenic proteins. This approach seeks to mitigate or eliminate the risks of severeallergic reactions while eliciting a protective immune response. The Company is focused on changing the approach to prevent allergic reactions at the molecular level, striving to offer a safer and more targeted alternative to conventional desensitization techniques. This will lessen the treatment burden while meeting the critical needs of those vulnerable to severe allergic reactions to peanuts, with possibilities for extending the solution to other major allergens like milk, tree nuts, and respiratory triggers. | $45M / Series C / Jan 08, 2026 | |
Ripple Foods
|
Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has thecreamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk.It was founded in 2014 and headquartered in Emeryville, California. | $17M / Dec 02, 2025 | |
Ansa Biotechnologies
|
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerateinnovation in biological research and engineering. | $46.4M / Series B / Oct 01, 2025 | |
Bonsai Robotics
|
Bonsai Robotics provides vision-based automation solutions for off-road vehicles, such as agricultural machines. The company also offers analytics and telematics to help growers improve their performance, efficiency, and safety. The company is based in San Jose, California. | $15M / Series A / Jan 28, 2025 | |
Vaulted Deep
|
Vaulted Deep provides proven technology solutions for permanent carbon removal to promote local environmental and community health. It is a spin-off of Advantek Waste Management Services. | $32.3M / Series A / Oct 02, 2024 | |
Arzeda
|
Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable. | $38M / Series C / Sep 17, 2024 | |
|
Arzeda
|
Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable. | $38M / Series B / Sep 17, 2024 | |
Micropep Technologies
|
Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control. | $29.3M / Series B / Jul 25, 2024 | |
|
Micropep Technologies
|
Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control. | $29.3M / Series B / Jul 25, 2024 | |
| See all 59 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Fall Line Capital invest in?
Fall Line Capital invests primarily in Biotechnology, Agriculture and AgTech startups, most often at Series A and Seed stage. Most of the 59 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Fall Line Capital's check size?
Fall Line Capital typically joins rounds of $3M–$14M at Seed, $7.5M–$32M at Series A and $19M–$46M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fall Line Capital participates in.
How do I contact Fall Line Capital?
Public channels for Fall Line Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fall Line Capital?
The team at Fall Line Capital includes Libby Spalding (Vice President), Wade Condrey (Head of Southern Operations) and Yanniv Dorone (Senior Vice President), among 14 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
